Global markets are reacting to geopolitical risks and policy shifts, and that volatility can push investors toward stronger balance sheets and clearer earnings trajectories. Indian high growth potential companies that analysts expect to lift profits over the next few years may appeal in this backdrop. This article walks through three stocks from a quality focused Indian growth screener so you can judge whether they deserve a closer look in your portfolio.
The three examples below are only a small sample from this idea. The full screen surfaced 141 more companies with similarly clear growth stories and balance sheet profiles that are not covered here. To identify and analyze the highest conviction opportunities that fit these filters, head straight into the Healthy high growth potential screener.
Overview: Shaily Engineering Plastics manufactures precision injection moulded plastic components, with a strong focus on pharma drug delivery devices alongside consumer and industrial products.
Operations: The business generates about ₹10.25b from customised plastic and other material components, reflecting its specialised manufacturing focus.
Market Cap: ₹138.45b
Shaily Engineering Plastics fits the Healthy high growth potential theme through its pharma CDMO work, where complex drug delivery devices can heavily influence earnings quality and future expansion.
"Although the GLP-1 opportunity is expanding rapidly worldwide and Shaily has onboarded a large roster of generic players across multiple countries, delays in regulatory approvals or slower than expected generic capture from innovators could cap utilization of its expanded pen capacity and temper healthcare revenue growth."
What happens to Shaily Engineering Plastics’ growth story if a single key assumption about future device volumes and pricing quietly shifts?
That quiet shift in assumptions is exactly what the full narrative for Shaily Engineering Plastics unpacks, highlighting where Shaily Engineering Plastics could see earnings decouple from headline device volumes.
Overview: Sky Gold and Diamonds designs, manufactures, and sells gold and diamond jewellery, with lab grown and American diamonds driving its growth focus.
Operations: The business generates around ₹71.76b from gold jewellery manufacturing, reflecting its primary revenue engine within the broader jewellery offering.
Market Cap: ₹127.76b
Sky Gold and Diamonds appeals to the Healthy high growth potential theme because its lab grown and synthetic diamond jewellery is positioned at the intersection of rising demand, higher margins, and an earnings profile that analysts expect to strengthen over the next few years.
"The shift towards lower karat products and lightweight jewelry helps manage consumer price points. However, it also compresses gold content per piece, which can cap value per unit sold and weigh on long term revenue growth if volume momentum slows."
The real test for Sky Gold and Diamonds now is how that evolving product mix interacts with one quiet pressure on long term profitability.
That quiet pressure is exactly what the full narrative for Sky Gold and Diamonds unpacks, showing where Sky Gold and Diamonds’ mix shift could either compress margins or accelerate earnings quality.
Overview: Cemindia Projects builds large marine structures and mass rapid transit systems across India, along with other complex civil engineering works.
Operations: Cemindia Projects generates about ₹102.05b from construction activity, largely within India, reflecting a focused heavy-civil contracting revenue base.
Market Cap: ₹199.15b
Cemindia Projects brings the Healthy high growth potential theme into hard infrastructure, where multi year marine and metro contracts can support earnings visibility, provided that execution keeps pace with the project pipeline.
"A shift toward technically advanced projects such as metro tunnels, marine works and specialized foundations, along with increasing adoption of precast construction, supports ITD Cementation's margin profile. These segments tend to offer higher net margins and are less susceptible to high competition and margin compression."
What matters now is how one less visible pressure on Cemindia Projects’ future order flow shapes that margin story over time.
That pressure is exactly what the full narrative for Cemindia Projects breaks down, separating cyclical noise from contract quality so you can evaluate how Cemindia Projects’ margin story may evolve.
Market momentum can shift fast, and the most interesting ideas rarely stay under the radar for long. Scan these fresh stock pools before the best entry points drop away, then act now.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com